PeptideStack
5.2kquestions
20kanswers
220users

What is the reported incidence of fatigue on cagrilintide in REDEFINE-1?

Asked 10 Oct 2025Modified 7 months agoViewed 9k times
28

For reference: fatigue · cagrilintide · REDEFINE-1.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

What is the correct interpretation, and what is the common misreading?

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
NP
askednet_peptide12k1510 Oct 2025

5 Answers

Accepted answer first, then by votes
28

Accepted answer

Take it from the REDEFINE-1 adverse-event table by arm, and check the unit before you use it. An incidence can be the proportion of participants who reported the event at least once, or the count of events divided by exposure time, and the two differ by however many people had it repeatedly. Then subtract the placebo arm, because the untreated rate is not zero. And read the discontinuation column beside it: an event that made people leave the trial is under-counted at every later visit, so a low late-timepoint incidence can mean the event was severe rather than rare.

Concretely, if it persists at an adequate intake, it needs blood work rather than more speculation.

A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.

Local reaction versus infection

FeatureLocal reactionSterile abscessCellulitis
OnsetHours to 2 daysDays1–4 days, progressive
WarmthAbsent or minimalMildMarked
ExpansionStatic or shrinkingSlowExpanding
TextureFirm, flat or raisedFluctuantDiffuse, indurated
Systemic featuresNoneNoneFever, malaise possible
ActionObserve, rotate siteClinical reviewSame-day clinical review

The part that matters: hypothyroidism, sleep apnoea, depression and anaemia all present as fatigue and all become more likely rather than less in this population, so attribution to the compound should be a diagnosis of exclusion.

Energy deficits above roughly a thousand kilocalories a day are associated with measurable reductions in resting metabolic rate, spontaneous activity and subjective energy in controlled studies.

Weigh three days of intake honestly. That answers this most of the time.

shareimprove this answerflag
SH
answered · acceptedseven_day_half31k13817 Dec 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
21

Answering this needs to know the size of the deficit, since fatigue tracks it closely and predictably.

Dehydration from reduced fluid intake alongside reduced food intake produces headache, lethargy and postural dizziness, and is the cheapest thing on the list to correct.

Iron deficiency is common, particularly in menstruating women, and low intake plus a reduced red-meat share makes it more likely. Ferritin is the test, and it is an acute-phase reactant so it needs interpreting alongside CRP.

Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.

The caveat is that fatigue with breathlessness, chest symptoms or sudden onset needs assessment rather than dietary adjustment.

Abrupt onset points away from the deficit and towards something else.

shareimprove this answerflag
CH
answeredcal_hennessy17k2728 Dec 2025
5The distinction between escalation-related and steady-state is the useful part. – two_point_four 12 days ago
add a comment
9

The honest answer is that this is usually fixable by eating more, which is unwelcome advice in this context.

Carbohydrate intake specifically affects training performance and perceived energy at a given total intake, which is why very low carbohydrate approaches feel worse in the gym at matched energy.

Three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.

If it persists at an adequate intake, get bloods rather than more theories.

shareimprove this answerflag
TU
answeredtenth_of_a_unit57k376 Dec 2025
8

This is the complaint with the widest differential and the one most often attributed too quickly.

Sleep quality often changes during rapid weight loss in both directions, and sleep debt produces fatigue that no amount of dietary adjustment will fix.

Sleep restriction produces measurable decrements in subjective energy and in training performance independently of energy intake.

Check fluid and sodium before anything more exotic.

edited 29 Nov 2025 by Dr_Ilse_Vandenberg — updated for the 2026 guidance change

shareimprove this answerflag
DV
answeredDr_Ilse_Vandenberg113k24825 Nov 2025
5

The short version: check intake, check hydration, check iron and thyroid if it persists, and only then attribute it to the compound.

Fatigue that appeared abruptly, rather than gradually with the deficit, is a different pattern and points away from intake.

Sleep is a variable here too, and no amount of eating fixes sleep debt.

edited 13 Nov 2025 by samir_bennani — reworded for clarity after a comment

shareimprove this answerflag
SB
answeredsamir_bennani15k2714 Oct 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.